Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 17, 2024

SELL
N/A
-718,026 Reduced 99.86%
1,022 $0
Q2 2024

Aug 14, 2024

SELL
N/A
-718,026 Reduced 99.86%
1,022 $0
Q1 2024

Oct 17, 2024

BUY
N/A
718,026 Added 70256.95%
719,048 $0
Q1 2024

Aug 16, 2024

SELL
N/A
-20 Reduced -0.0%
719,048 $0
Q1 2024

May 15, 2024

SELL
N/A
-20 Reduced -0.0%
719,048 $0
Q4 2023

Aug 16, 2024

BUY
N/A
718,046 Added 70258.9%
719,068 $0
Q4 2023

Feb 13, 2024

BUY
N/A
200 Added 0.03%
719,068 $0
Q4 2022

Feb 14, 2023

SELL
N/A
-400 Reduced 0.06%
718,868 $0
Q4 2021

Feb 14, 2022

BUY
N/A
1,001 Added 0.14%
719,268 $1.61 Million
Q3 2021

Nov 15, 2021

BUY
N/A
718,267 New
718,267 $2.44 Million

Others Institutions Holding DNAWS

About GINKGO BIOWORKS HLDGS INC WT E


  • Ticker DNAWS
More about DNAWS
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.